Ara
Toplam kayıt 2, listelenen: 1-2
COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul
(Blackwell Publishing Inc., 2020)
Introduction: Management of COVID-19 in kidney transplant recipients should include treatment of the infection, regulation of immunosuppression, and supportive therapy. However, there is no consensus on this issue yet. ...
What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?
(Aves, 2022)
Objective: Recommendations for the treatment of cytokine release syndrome/macrophage activation syndrome (MAS) associated with coronavirus disease-2019 (COVID-19) are still of poor quality. IL-6 is an important therapeutic ...